The US witnessed an increase in synthetic opioid-related deaths after 2013, mainly due to the rapid proliferation of ...

HB 241 would require health insurers to cover physical therapy, acupuncture, massage therapy, and chiropractic care as ...

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a leading biotechnology company specializing in cystic fibrosis (CF) treatments, has been making significant strides in expanding its therapeutic portfolio ...

Among patients seen at an orthopedic clinic, 81.3% were open to receiving THC-based products and 90.1% were open to receiving ...

Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...

OxyContin maker Purdue Pharma and its owners agreed to pay up to $7.4 billion in a new settlement, officials in Mass. and ...

Through life experiences and relationships, it’s hard not to cross paths with people who’ve been impacted by the opioid crisis. Maybe they themselves dealt with opioid abuse or perhaps have ...

Purdue Pharma and its owners, the Sackler family, have reached a $7.4bn settlement with US states to resolve a long-running ...

Cebranopadol reduced pain intensity in patients following abdominoplasty surgery in the ALLEVIATE-1 clinical trial.

An Empire of Misery and a Legacy of Opioids. The Sackler family, once revered for its wealth and philanthropic endeavours, is ...

Paul Howe, chief commercial officer at Protega, discusses efforts to combine high tech solutions with pain-management medications.

Purdue Pharma and its Sackler family owners have reached a new opioid settlement to resolve thousands of lawsuits.